United States Vaccine Conjugate Market Report 2017

October 2017 | 97 pages | ID: UBCC73AB72DPEN
QYResearch

Abstracts

In this report, the United States Vaccine Conjugate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Vaccine Conjugate in these regions, from 2012 to 2022 (forecast).

United States Vaccine Conjugate market competition by top manufacturers/players, with Vaccine Conjugate sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck & Co., Inc.
• GlaxoSmithKline plc.
• SutroVax Inc.
• Fablife.
• Pfizer
• Sinovac Biotech Ltd.
• Sanofi Pasteur SA.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Monovalent
• Multivalent
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Vaccine Conjugate for each application, including

• Influenza
• Meningococcal
• Pneumococcal
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Vaccine Conjugate Market Report 2017

1 VACCINE CONJUGATE OVERVIEW

1.1 Product Overview and Scope of Vaccine Conjugate
1.2 Classification of Vaccine Conjugate by Product Category
  1.2.1 United States Vaccine Conjugate Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Vaccine Conjugate Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Monovalent
  1.2.4 Multivalent
  1.2.5 Others
1.3 United States Vaccine Conjugate Market by Application/End Users
  1.3.1 United States Vaccine Conjugate Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Influenza
  1.3.3 Meningococcal
  1.3.4 Pneumococcal
  1.3.5 Others
1.4 United States Vaccine Conjugate Market by Region
  1.4.1 United States Vaccine Conjugate Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Vaccine Conjugate Status and Prospect (2012-2022)
  1.4.3 Southwest Vaccine Conjugate Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Vaccine Conjugate Status and Prospect (2012-2022)
  1.4.5 New England Vaccine Conjugate Status and Prospect (2012-2022)
  1.4.6 The South Vaccine Conjugate Status and Prospect (2012-2022)
  1.4.7 The Midwest Vaccine Conjugate Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Vaccine Conjugate (2012-2022)
  1.5.1 United States Vaccine Conjugate Sales and Growth Rate (2012-2022)
  1.5.2 United States Vaccine Conjugate Revenue and Growth Rate (2012-2022)

2 UNITED STATES VACCINE CONJUGATE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Vaccine Conjugate Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Vaccine Conjugate Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Vaccine Conjugate Average Price by Players/Suppliers (2012-2017)
2.4 United States Vaccine Conjugate Market Competitive Situation and Trends
  2.4.1 United States Vaccine Conjugate Market Concentration Rate
  2.4.2 United States Vaccine Conjugate Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Vaccine Conjugate Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES VACCINE CONJUGATE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Vaccine Conjugate Sales and Market Share by Region (2012-2017)
3.2 United States Vaccine Conjugate Revenue and Market Share by Region (2012-2017)
3.3 United States Vaccine Conjugate Price by Region (2012-2017)

4 UNITED STATES VACCINE CONJUGATE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Vaccine Conjugate Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Vaccine Conjugate Revenue and Market Share by Type (2012-2017)
4.3 United States Vaccine Conjugate Price by Type (2012-2017)
4.4 United States Vaccine Conjugate Sales Growth Rate by Type (2012-2017)

5 UNITED STATES VACCINE CONJUGATE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Vaccine Conjugate Sales and Market Share by Application (2012-2017)
5.2 United States Vaccine Conjugate Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES VACCINE CONJUGATE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck & Co., Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Vaccine Conjugate Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck & Co., Inc. Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline plc.
  6.2.2 Vaccine Conjugate Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline plc. Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 SutroVax Inc.
  6.3.2 Vaccine Conjugate Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 SutroVax Inc. Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Fablife.
  6.4.2 Vaccine Conjugate Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Fablife. Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.2 Vaccine Conjugate Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sinovac Biotech Ltd.
  6.6.2 Vaccine Conjugate Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sinovac Biotech Ltd. Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi Pasteur SA.
  6.7.2 Vaccine Conjugate Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi Pasteur SA. Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 VACCINE CONJUGATE MANUFACTURING COST ANALYSIS

7.1 Vaccine Conjugate Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Vaccine Conjugate

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Vaccine Conjugate Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Vaccine Conjugate Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VACCINE CONJUGATE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Vaccine Conjugate Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Vaccine Conjugate Sales Volume Forecast by Type (2017-2022)
11.3 United States Vaccine Conjugate Sales Volume Forecast by Application (2017-2022)
11.4 United States Vaccine Conjugate Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Vaccine Conjugate
Figure United States Vaccine Conjugate Market Size (K MT) by Type (2012-2022)
Figure United States Vaccine Conjugate Sales Volume Market Share by Type (Product Category) in 2016
Figure Monovalent Product Picture
Figure Multivalent Product Picture
Figure Others Product Picture
Figure United States Vaccine Conjugate Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Vaccine Conjugate by Application in 2016
Figure Influenza Examples
Table Key Downstream Customer in Influenza
Figure Meningococcal Examples
Table Key Downstream Customer in Meningococcal
Figure Pneumococcal Examples
Table Key Downstream Customer in Pneumococcal
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Vaccine Conjugate Market Size (Million USD) by Region (2012-2022)
Figure The West Vaccine Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Vaccine Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Vaccine Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Vaccine Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Vaccine Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Vaccine Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Vaccine Conjugate Sales (K MT) and Growth Rate (2012-2022)
Figure United States Vaccine Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Vaccine Conjugate Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Vaccine Conjugate Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Vaccine Conjugate Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Vaccine Conjugate Sales Share by Players/Suppliers
Figure 2017 United States Vaccine Conjugate Sales Share by Players/Suppliers
Figure United States Vaccine Conjugate Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Vaccine Conjugate Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Vaccine Conjugate Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Vaccine Conjugate Revenue Share by Players/Suppliers
Figure 2017 United States Vaccine Conjugate Revenue Share by Players/Suppliers
Table United States Market Vaccine Conjugate Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Vaccine Conjugate Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Vaccine Conjugate Market Share of Top 3 Players/Suppliers
Figure United States Vaccine Conjugate Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Vaccine Conjugate Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Vaccine Conjugate Product Category
Table United States Vaccine Conjugate Sales (K MT) by Region (2012-2017)
Table United States Vaccine Conjugate Sales Share by Region (2012-2017)
Figure United States Vaccine Conjugate Sales Share by Region (2012-2017)
Figure United States Vaccine Conjugate Sales Market Share by Region in 2016
Table United States Vaccine Conjugate Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Vaccine Conjugate Revenue Share by Region (2012-2017)
Figure United States Vaccine Conjugate Revenue Market Share by Region (2012-2017)
Figure United States Vaccine Conjugate Revenue Market Share by Region in 2016
Table United States Vaccine Conjugate Price (USD/MT) by Region (2012-2017)
Table United States Vaccine Conjugate Sales (K MT) by Type (2012-2017)
Table United States Vaccine Conjugate Sales Share by Type (2012-2017)
Figure United States Vaccine Conjugate Sales Share by Type (2012-2017)
Figure United States Vaccine Conjugate Sales Market Share by Type in 2016
Table United States Vaccine Conjugate Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Vaccine Conjugate Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Vaccine Conjugate by Type (2012-2017)
Figure Revenue Market Share of Vaccine Conjugate by Type in 2016
Table United States Vaccine Conjugate Price (USD/MT) by Types (2012-2017)
Figure United States Vaccine Conjugate Sales Growth Rate by Type (2012-2017)
Table United States Vaccine Conjugate Sales (K MT) by Application (2012-2017)
Table United States Vaccine Conjugate Sales Market Share by Application (2012-2017)
Figure United States Vaccine Conjugate Sales Market Share by Application (2012-2017)
Figure United States Vaccine Conjugate Sales Market Share by Application in 2016
Table United States Vaccine Conjugate Sales Growth Rate by Application (2012-2017)
Figure United States Vaccine Conjugate Sales Growth Rate by Application (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Vaccine Conjugate Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Vaccine Conjugate Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. Vaccine Conjugate Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline plc. Basic Information List
Table GlaxoSmithKline plc. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. Vaccine Conjugate Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. Vaccine Conjugate Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline plc. Vaccine Conjugate Revenue Market Share in United States (2012-2017)
Table SutroVax Inc. Basic Information List
Table SutroVax Inc. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure SutroVax Inc. Vaccine Conjugate Sales Growth Rate (2012-2017)
Figure SutroVax Inc. Vaccine Conjugate Sales Market Share in United States (2012-2017)
Figure SutroVax Inc. Vaccine Conjugate Revenue Market Share in United States (2012-2017)
Table Fablife. Basic Information List
Table Fablife. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Fablife. Vaccine Conjugate Sales Growth Rate (2012-2017)
Figure Fablife. Vaccine Conjugate Sales Market Share in United States (2012-2017)
Figure Fablife. Vaccine Conjugate Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Vaccine Conjugate Sales Growth Rate (2012-2017)
Figure Pfizer Vaccine Conjugate Sales Market Share in United States (2012-2017)
Figure Pfizer Vaccine Conjugate Revenue Market Share in United States (2012-2017)
Table Sinovac Biotech Ltd. Basic Information List
Table Sinovac Biotech Ltd. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sinovac Biotech Ltd. Vaccine Conjugate Sales Growth Rate (2012-2017)
Figure Sinovac Biotech Ltd. Vaccine Conjugate Sales Market Share in United States (2012-2017)
Figure Sinovac Biotech Ltd. Vaccine Conjugate Revenue Market Share in United States (2012-2017)
Table Sanofi Pasteur SA. Basic Information List
Table Sanofi Pasteur SA. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Pasteur SA. Vaccine Conjugate Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur SA. Vaccine Conjugate Sales Market Share in United States (2012-2017)
Figure Sanofi Pasteur SA. Vaccine Conjugate Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vaccine Conjugate
Figure Manufacturing Process Analysis of Vaccine Conjugate
Figure Vaccine Conjugate Industrial Chain Analysis
Table Raw Materials Sources of Vaccine Conjugate Major Players/Suppliers in 2016
Table Major Buyers of Vaccine Conjugate
Table Distributors/Traders List
Figure United States Vaccine Conjugate Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Vaccine Conjugate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Vaccine Conjugate Price (USD/MT) Trend Forecast (2017-2022)
Table United States Vaccine Conjugate Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Vaccine Conjugate Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Vaccine Conjugate Sales Volume (K MT) Forecast by Type in 2022
Table United States Vaccine Conjugate Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Vaccine Conjugate Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Vaccine Conjugate Sales Volume (K MT) Forecast by Application in 2022
Table United States Vaccine Conjugate Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Vaccine Conjugate Sales Volume Share Forecast by Region (2017-2022)
Figure United States Vaccine Conjugate Sales Volume Share Forecast by Region (2017-2022)
Figure United States Vaccine Conjugate Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources